论文部分内容阅读
维脑路通作为治疗缺铁性脑血管病的重要药物以来,受到医务人员的普遍重视,近年来有应用大剂量维脑路通的报道,为此,我们用大剂量(为常规量的5～20倍)维脑路通(即系治疗组共56例)与常规剂量(对照组50例)进行治疗对比观察。治疗组用低分子右旋糖酐500ml加维脑路通2～8g静滴,每日一次,15次为一疗程(维脑路通从2g开始,每日递增1g,至8g为止);对照组用低分子右旋糖酐500ml加维脑路通400mg静滴,15次为一疗程。结果表明,对照组有效率为90％,治疗组有效率为90.8％,与对照组无显著差异,P<0.05,其疗效不随剂量增加而提高,应用常规量即可收到满意效果。同时观察到,副作用的出现与用药剂量
As an important drug for the treatment of iron deficiency cerebrovascular disease, Viagra has received universal attention from medical staff. In recent years, there have been reports of using large doses of Venoruton. For this reason, we used a large dose of 5 ~ 20 times) Venoruton (ie, the treatment group, a total of 56 cases) and the conventional dose (50 cases in the control group) were compared. The treatment group with low molecular weight dextran 500ml plus Venoruton 2 ~ 8g intravenous infusion once a day, 15 times for a course of treatment (Venoruton from 2g, daily 1g, up to 8g date); control group with low Molecular dextran 500ml plus verapamil 400mg intravenous infusion, 15 times for a course of treatment. The results showed that the effective rate of the control group was 90%, the effective rate of the treatment group was 90.8%, no significant difference with the control group, P <0.05, the efficacy does not increase with the dose increased, the conventional amount can receive satisfactory results. Also observed, the emergence of side effects and dosage